Guillaume Cartron, Florence Hourcade-Potelleret, Franck Morschhauser, Gilles Salles, Michael Wenger, Anna Truppel-Hartmann and David J. Carlile (2016) “Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphoma”, Haematologica. Pavia, Italy, 101(2), pp. 226-234. doi: 10.3324/haematol.2015.133421.